Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Fidelity Select Pharmaceuticals Portfolio

+ Add to Watchlist

FPHAX:US

23.08 USD 0.10 0.43%

As of 09:29:30 ET on 02/27/2015.

Snapshot for Fidelity Select Pharmaceuticals Portfolio (FPHAX)

Year To Date: +7.95% 3-Month: +5.82% 3-Year: +27.63% 52-Week Range: 17.81 - 23.18
1-Month: +5.92% 1-Year: +20.04% 5-Year: +23.21% Beta vs MXWO: 0.89

Mutual Fund Chart for FPHAX

No chart data available.
  • FPHAX:US 23.08
  • 1M
  • 1Y
Interactive FPHAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FPHAX

Fidelity Select Pharmaceuticals Portfolio is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types.

Inception Date: 06-18-2001 Telephone: 1-800-544-6666
Managers: ASHER ANOLIC
Web Site: www.fidelity.com

Fundamentals for FPHAX

NAV (on 2015-02-27) 23.08
Assets (M) (on 2015-01-30) 1,768.03
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for FPHAX

Dividend Type Income
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-12-19) 0.09
Dividend Yield (ttm) 9.55

Fees & Expenses for FPHAX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.55
Redemption Fee 0.75
12b1 Fee 0.00
Expense Ratio 0.81

Top Fund Holdings for FPHAX

Filing Date: 12/31/2014
Name Position Value % of Total
Actavis plc 556,307 143,198,985 8.256%
Sanofi 2,644,722 120,625,770 6.954%
Johnson & Johnson 1,041,700 108,930,569 6.280%
Bristol-Myers Squibb Co 1,701,910 100,463,747 5.792%
Novartis AG 837,698 77,621,097 4.475%
Teva Pharmaceutical Industries 1,249,489 71,858,112 4.143%
Perrigo Co PLC 410,352 68,594,440 3.955%
Allergan Inc/United States 284,700 60,524,373 3.489%
Novo Nordisk A/S 1,409,000 59,628,880 3.438%
AstraZeneca PLC 752,200 52,939,836 3.052%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil